» Articles » PMID: 35907808

The Potential Performance of Serum Albumin to Globulin Ratio, Albumin and Globulin in the Diagnosis of Periprosthetic Joint Infection and Prediction of Reinfection Following Reimplantation

Overview
Publisher Biomed Central
Specialties Orthopedics
Physiology
Date 2022 Jul 30
PMID 35907808
Authors
Affiliations
Soon will be listed here.
Abstract

Background: This study was conducted to evaluate the performance of serum albumin (ALB), globulin (GLO), and albumin to globulin ratio (AGR) in the diagnosis of PJI and prediction of reinfection following reimplantation in PJI patients who underwent two-stage revision.

Methods: We perform a retrospective data collection on identified patients who underwent revision arthroplasties in our institution from January 2010 to January 2020. A total of 241 patients were stratified into: group A (PJI), group B (aseptic loosening). Fifty-five patients who underwent two-stage revision in group A were assigned to group C. Group C was stratified into subgroup 1 (reinfection) and subgroup 2 (non-reinfection). Receiver operating characteristic curves were used to evaluate the utility of serum markers for diagnosing PJI and predicting reinfection following reimplantation.

Results: In the diagnosis of PJI, there were significant differences in the levels of ALB, GLO, and AGR between groups A and group B (P < 0.05). The AUC value of serum AGR (0.851) was similar to ESR (0.841) and CRP (0.866) (all p > 0.05). The AUC values of serum ALB and GLO were 0.757 and 0.753, respectively. As for predicting reinfection following reimplantation, the serum ALB in the non-reinfection group was higher than that in the reinfection group (p = 0.041). The AUC value of serum ALB was 0.7.

Conclusion: AGR was promising adjunct marker for the diagnosis of PJI, similar to CRP and ESR. ALB and GLO have an acceptable value for the diagnosis of PJI. ALB may be expected to be a kind of effective marker for predicting reinfection following reimplantation.

Citing Articles

Identifying potential predictive indicators for reimplantation timing in two-stage revision: a meta-analysis and system review.

Zhang Q, Li H, Xie H, Liu L, Chen L, Zeng Y Arch Orthop Trauma Surg. 2024; 145(1):88.

PMID: 39714508 DOI: 10.1007/s00402-024-05689-5.


Diagnostic value of neutrophil-to-lymphocyte ratio and albumin-to-globulin ratio for periprosthetic joint infections: a systematic review and meta-analysis.

Chen C, Chen Y, Kuo Y, Liu Y, Huang S EFORT Open Rev. 2024; 9(12):1134-1143.

PMID: 39620558 PMC: 11619729. DOI: 10.1530/EOR-23-0206.


Serum albumin-to-globulin ratio and CRP-to-albumin ratio did not outperform serum CRP in diagnosing periprosthetic joint infections.

Luger M, Bohler C, Puchner S, Apprich S, Staats K, Windhager R Bone Joint Res. 2024; 13(8):372-382.

PMID: 39084635 PMC: 11290946. DOI: 10.1302/2046-3758.138.BJR-2024-0032.R1.


Diagnostic value of procalcitonin in patients with periprosthetic joint infection: a diagnostic meta-analysis.

Sun X, Li Y, Lv Y, Liu Y, Lai Z, Zeng Y Front Surg. 2024; 11:1211325.

PMID: 38660585 PMC: 11039863. DOI: 10.3389/fsurg.2024.1211325.


Serum procalcitonin has no significance in the diagnosis of periprosthesis joint infection before total hip and knee replacement.

Sun X, Zhang H, Liu Y, Lai Z, Zeng Y Front Surg. 2023; 10:1216103.

PMID: 38026480 PMC: 10657873. DOI: 10.3389/fsurg.2023.1216103.


References
1.
Huotari K, Peltola M, Jamsen E . The incidence of late prosthetic joint infections: a registry-based study of 112,708 primary hip and knee replacements. Acta Orthop. 2015; 86(3):321-5. PMC: 4443453. DOI: 10.3109/17453674.2015.1035173. View

2.
Yi P, Cross M, Moric M, Sporer S, Berger R, Della Valle C . The 2013 Frank Stinchfield Award: Diagnosis of infection in the early postoperative period after total hip arthroplasty. Clin Orthop Relat Res. 2013; 472(2):424-9. PMC: 3890203. DOI: 10.1007/s11999-013-3089-1. View

3.
Jin Y, Zhao L, Peng F . Prognostic impact of serum albumin levels on the recurrence of stage I non-small cell lung cancer. Clinics (Sao Paulo). 2013; 68(5):686-93. PMC: 3654299. DOI: 10.6061/clinics/2013(05)17. View

4.
Toiyama Y, Yasuda H, Ohi M, Yoshiyama S, Araki T, Tanaka K . Clinical impact of preoperative albumin to globulin ratio in gastric cancer patients with curative intent. Am J Surg. 2016; 213(1):120-126. DOI: 10.1016/j.amjsurg.2016.05.012. View

5.
Chi J, Xie Q, Jia J, Liu X, Sun J, Chen J . Prognostic Value of Albumin/Globulin Ratio in Survival and Lymph Node Metastasis in Patients with Cancer: A Systematic Review and Meta-analysis. J Cancer. 2018; 9(13):2341-2348. PMC: 6036713. DOI: 10.7150/jca.24889. View